This analysis examines the current position and future outlook for Roche in the ethical pharmaceutical sector. The profile encompasses global and US company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information

• Benchmark Roche's performance against key rivals in the ethical pharmaceutical sector
• Understand why Roche's forecasted generic risk is one of the lowest in the pharmaceutical industry
• Learn which therapeutic areas are forecast to drive Roche's growth to 2010